Phycin, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Phycin, Inc. - overview

Established

2013

Location

Frederick, MD, US

Primary Industry

Biotechnology

About

Based in Maryland, US, and founded in 2013, Phycin, Inc. , a. k. a.


Phycin operates as a biotechnology company that leverages algae to produce growth factors for various applications, such as regenerative medicine, cultivated meat, cosmetics and more. In June 2024, Phycin, Inc. raised USD 0. 2 million in seed funding from TEDCO.


As of June 2024, Jun Wang is the CEO of the company. Phycin’s products cater to multiple industries, including eye care, cell culture media, and clean meat production. For eye care, Phycin offers a novel therapy for corneal injuries, addressing the lack of approved treatments for such conditions. In cell culture media, Phycin’s algae-based growth factors optimize cell growth, differentiation, and proliferation, crucial for regenerative medicine and biomedical research.


For clean meat production, Phycin provides food-grade growth factors that are safe, versatile, and economically viable, supporting the commercial production of lab-grown meat. The company plans to use its proceeds from June 2024 funding to expand its market reach and improve research and development efforts.


Current Investors

Primary Industry

Biotechnology

Sub Industries

Biotechnology

Website

www.phycin.com

Verticals

Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.